UBS Group’s Forbion European Acquisition Corp. Class A Ordinary Shares FRBN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-25,000
Closed -$253K 11422
2022
Q3
$253K Hold
25,000
﹤0.01% 4892
2022
Q2
$249K Hold
25,000
﹤0.01% 4751
2022
Q1
$249K Buy
+25,000
New +$248K ﹤0.01% 5192

Other funds holding FRBN

UBS Group's FRBN Position: Q4 2022 in Review

UBS Group sold out of Forbion European Acquisition Corp. Class A Ordinary Shares (FRBN) in Q4 2022, closing a stake of 25,000 shares — an estimated $253K sold.

UBS Group first reported a position in FRBN in Q1 2022 and held it in 3 quarters. The position peaked at $253K in Q3 2022. 30 funds tracked by Wall St. Rank hold FRBN as of Q4 2022.

  • UBS Group reported no remaining Forbion European Acquisition Corp. Class A Ordinary Shares position as of Q4 2022 after selling out during the quarter.
  • UBS Group sold 25,000 Forbion European Acquisition Corp. Class A Ordinary Shares shares in Q4 2022, an estimated $253K.
  • UBS Group first reported a position in Forbion European Acquisition Corp. Class A Ordinary Shares in Q1 2022 and held it in 3 quarters.
  • UBS Group's Forbion European Acquisition Corp. Class A Ordinary Shares position peaked at $253K in Q3 2022.
  • 30 funds tracked by Wall St. Rank held Forbion European Acquisition Corp. Class A Ordinary Shares as of Q4 2022.

Based on UBS Group's 13F filing for Q4 2022, filed 8 Feb 2023.